Karyopharm therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Newton, mass., feb. 1, 2021 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the compensation committee of karyopharm's board of directors granted stock options to purchase an...
KPTI Ratings Summary
KPTI Quant Ranking